SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C-AR - Annual Report:
SEC Accession No. 0001665160-23-000924
Filing Date
2023-04-27
Accepted
2023-04-27 14:53:03
Documents
2
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 3769
2 form_car.pdf EX-99 63630643
  Complete submission text file 0001665160-23-000924.txt   86763756
Mailing Address 2155 E CONFERENCE DR STE 115 STE 115 TEMPE AZ 85284
Business Address 2155 E CONFERENCE DR. STE 115 TEMPE AZ 85284 480-939-5770
iMetabolic Biopharma Corp (Filer) CIK: 0001957114 (see all company filings)

IRS No.: 823644889 | State of Incorp.: NV | Fiscal Year End: 1231
Type: C-AR | Act: 33 | File No.: 020-31493 | Film No.: 23855738